Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diclofenac diethylamine + methyl salicylate + menthol
- Development stage
- Unknown
- Lead developer
- BLS Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Relifast Pain Relief Spray is a topical analgesic formulation developed and marketed by BLS Pharma (Belfast Life Sciences) in Pakistan. It is designed for the symptomatic relief of musculoskeletal pain, including backache, joint pain, muscle strains, and sprains. The spray contains a combination of active ingredients: **diclofenac diethylamine**, a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes; **methyl salicylate**, a counter-irritant that induces local vasodilation and provides a warming sensation; and **menthol**, which provides a cooling effect and acts as a mild local anesthetic by interacting with cold-sensitive receptors. This multi-action formulation allows for rapid absorption and localized relief at the site of injury or inflammation.
- Brand names
- Relifast Pain Relief Spray
- Other names
- Relifast SprayRelifast
02
Targets
TRPV1 (Transient receptor potential cation channel subfamily V member 1)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on diclofenac diethylamine + methyl salicylate + menthol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diclofenac diethylamine + methyl salicylate + menthol.